SynbioTech to Present TWK10® Research and Microbiome CDMO Platform in the Emerging GLP-1 Companion-Nutrition Market at Vitafoods Asia 2026
Aug 26, 2026
Kaohsiung [Taiwan], August 26: As GLP-1-based therapies reshape weight management, brands are looking beyond appetite control to nutrition quality, protein utilization, muscle support and long-term vitality. Nutrition conversations increasingly connect to women's healthy aging and active living. SynbioTech, the world-leading biotechnology company specializing in probiotics, postbiotics and microbiome-based health solutions, will present internationally renowned Lactiplantibacillus plantarum TWK10® and its integrated microbiome CDMO platform to this discussion at Vitafoods Asia 2026, taking place from 2-4 September at the Queen Sirikit National Convention Center in Bangkok. The Taiwan-based biotechnology company will exhibit at Booth H7-N32B. Backed by gut-muscle axis research, 27 scientific publications and multi-market readiness, TWK10 ® beyond appetite control.
